Champions Oncology, Inc.CSBRNASDAQ
Loading
Year-over-year gross profit growth rate
Percentile
P36
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q1 2026 | -0.43% |
| Q4 2025 | 31.44% |
| Q3 2025 | 20.30% |
| Q2 2025 | -53.21% |
| Q1 2025 | 77.04% |
| Q4 2024 | -13.43% |
| Q3 2024 | -3.13% |
| Q2 2024 | 61.89% |
| Q1 2024 | -15.84% |
| Q4 2023 | 1.60% |
| Q3 2023 | -14.93% |
| Q2 2023 | 12.99% |
| Q1 2023 | -25.80% |
| Q4 2022 | 2.17% |
| Q3 2022 | 0.56% |
| Q2 2022 | -1.93% |
| Q1 2022 | 9.88% |
| Q4 2021 | 5.46% |
| Q3 2021 | 19.24% |
| Q2 2021 | -20.63% |
| Q1 2021 | 38.36% |
| Q4 2020 | 6.22% |
| Q3 2020 | 12.02% |
| Q2 2020 | -19.80% |
| Q1 2020 | 25.19% |
| Q4 2019 | 25.43% |
| Q3 2019 | -12.62% |
| Q2 2019 | 13.83% |
| Q1 2019 | -7.43% |
| Q4 2018 | 3.18% |
| Q3 2018 | 49.41% |
| Q2 2018 | -19.39% |
| Q1 2018 | 2.31% |
| Q4 2017 | 6.65% |
| Q3 2017 | 108.09% |
| Q2 2017 | -0.86% |
| Q1 2017 | -48.58% |
| Q4 2016 | 96.51% |
| Q3 2016 | 131.72% |
| Q2 2016 | 10.99% |